CLINICAL TRIAL: AACTG 5188 - PHASE II TRANSDERMAL CONTRACEPTIVE SYSTEM IN HIV-1

临床试验：AACTG 5188 - HIV-1 的 II 期透皮避孕系统

• 批准号: 7716809
• 负责人: KRISTINE B. PATTERSON
• 金额: $ 0.06万
• 依托单位: UNIV OF NORTH CAROLINA CHAPEL HILL
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-04-02 至 2008-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7716809
• 关键词: AIDS clinical trial group; Anti-HIV Agents; Clinical Trials; Computer Retrieval of Information on Scientific Projects Database; Contraceptive Agents; Funding; Grant; HIV-1; Hormones; Institution; Lopinavir/Ritonavir; Ortho Evra; Ortho-Novum; Pharmaceutical Preparations; Phase; Research; Research Personnel; Resources; Source; System; Testing; Time; United States Food and Drug Administration; United States National Institutes of Health; Woman; birth control; pill

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This study will look at the hormone levels in the body after taking two different types of birth control, the ORTHO EVRA patch and the ORTHO NOVUM pill. It is not known if taking ORTHO EVRA or ORTHO NOVUM and your anti-HIV medication at the same time will change the amount of hormone or anti-HIV drug levels in your body. Both have been approved by the FDA but they have not been tested in HIV-1 infected women taking Kaletra before.

这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者所在的机构。 这项研究将观察服用两种不同类型的避孕药后体内的激素水平，即ORTHO EVRA贴片和ORTHO NOVUM药丸。 目前尚不清楚同时服用ORTHO EVRA或ORTHO NOVUM和抗HIV药物是否会改变您体内的激素量或抗HIV药物水平。 这两种药物都已获得FDA的批准，但此前从未在服用Kaletra的HIV-1感染妇女中进行过测试。